October 10th, 2011

Easier, costlier stroke prevention lies ahead

By

The experimental drug Eliquis generated a lot of buzz last month among heart experts. That's because study results presented in Europe suggested that patients on the new drug had both fewer strokes and fewer cases of major bleeds than those who took warfarin. Dr. Bernard Gersh of the Mayo Clinic in Rochester, Minn., contributed to the study and called it a "very positive trial." Even so, Gersh sought to temper excitement for the warfarin alternatives. "Everybody loves to hate warfarin, but they forget one thing - it's been around for 56 years and it's extremely effective," Gersh said. "It's inconvenient, but it's also very cheap."

Pioneer Press, by Christopher Snowbeck, 10/10/11

Tags: Cardiology

Contact Us · Privacy Policy